Physicians Teach on Myocardial Infarction on CME Webcast

OSUWexnerbloglogo2014 Physicians Teach On Myocardial Infarction on CME Webcast. The first Wallstent in a coronary artery was placed by Dr. Jacques Puel in France in 1986. He initially just called it a coronary endo-prosthesis but later called it a stent. Now, 30 years later, 2 million stents are implanted worldwide every year. One of the most important indications for them is to treat myocardial infarction. On this CME webcast, we’re going to update you on myocardial infarction: its pathogenesis, its treatment, and its complications. We’re pleased to introduce our guest speakers. Dr. Dean Boudoulas is an Associate Professor of Internal Medicine and the Director of the cardiac catheterization lab at the OSU Wexner Medical Center. And Dr. Cindy Baker is an Assistant Professor of Internal Medicine and the director of peripheral vascular interventions at Ohio State.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Learn how to diagnosis and manage UA/NSTEMI; Learn secondary prevention measures for UA/NSTEMI; Discuss reperfusion strategies and medical therapy in ST elevation myocardial; and Discuss complications of myocardial infarction.

You’ll also learn about the following:

  • Risk factors for coronary artery disease
  • STEMI versus non-STEMI
  • Myocardial infarction presentation in women
  • Cardiac rehabilitation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Cardiomyopathy

OSUWexnerbloglogo2014CME Webcasts Teaches on Cardiomyopathy. On this CME webcast, we are going to give you the information you need to be able to recognize cardiomyopathy in your patients and then to be able to identify the specific cause of their cardiomyopathy. Joining our moderator in the studio are two cardiologists from the Ohio State University. Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials at Ohio State. And Dr. Brent Lampert is an Assistant Professor of Internal Medicine and the Associate Program Director for the heart failure and transplant fellowship.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common presenting signs and symptoms of cardiomyopathy; and REVIEW the diagnostic work up for cardiomyopathy.

You’ll also learn about the following:

  • Common causes of cardiomyopathy
  • Initial diagnostic steps in cardiomyopathy
  • Follow up imaging in patients with cardiomyopathy
  • Myocardial sarcoidosis
  • Physical examination of hypertrophic cardiomyopathy
  • Takotsubo cardiomyopathy
  • Diagnosing restrictive cardiomyopathies
  • Significance and work up of diastolic dysfunction
  • Chemotherapy-induced cardiomyopathy
  • Chagas Disease (Trypanosoma infection)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Heart Disease in Women

OSUWexnerbloglogo2014 Learn about Heart Disease in Women on our latest webcast. Heart disease is different between men and women, the symptoms can be different and even the types of heart diseases can be different.  Joining our moderator, Dr. Jim Allen, in the studio to update us on heart disease in women is Associate Professor of Internal Medicine and the Director of the Women’s Cardiovascular Health Program at the Ohio State University, Dr. Laxmi Mehta.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the risk factors and clinical presentation of cardiovascular disease in women; and REVIEW causes of myocardial infarction in women without obstructive coronary artery disease.

You’ll also learn about the following:

  • Gender differences in cardiovascular disease symptoms and outcomes
  • Gender differences in heart disease epidemiology
  • Gender differences in cardiovascular stress tests
  • Statins and aspirin in women
  • Birth control pills and cardiovascular disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.